Mumps Research Today is a free monthly online journal that collates and summarizes the latest research about Mumps, including details on symptoms, vaccine, adult, causes.

Volume 2 (2005), Issue 9 (September)

1. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
   Pediatrics, 116(3): e397-407. [Abstract] [Full-text]
2. Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G.
   Vaccine, 23(41): 4921-5. [Abstract] [Full-text]
3. Assessment of sociodemographic factors and socio-economic status affecting the coverage of compulsory and private immunization services in Istanbul, Turkey.
   Public Health, 119(10): 862-9. [Abstract] [Full-text]
4. Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.
   J Clin Microbiol, 43(9): 4847-51. [Abstract] [Full-text]
5. Parents' reported reasons for avoiding MMR vaccination. A telephone survey.
   Scand J Prim Health Care, 23(3): 149-53. [Abstract] [Full-text]
6. Vaccination coverage among adolescents in certain provinces of Greece.
   Acta Paediatr, 94(8): 1122-5. [Abstract] [Full-text]

© 2004-2008 Mumps Research Today. All Rights Reserved.